3/12
07:08 am
alks
Alkermes Announces Inaugural Alkermes Pathways APN Research Awards™ Program [Yahoo! Finance]
Low
Report
Alkermes Announces Inaugural Alkermes Pathways APN Research Awards™ Program [Yahoo! Finance]
3/12
07:00 am
alks
Alkermes Announces Inaugural Alkermes Pathways APN Research Awards™ Program
Low
Report
Alkermes Announces Inaugural Alkermes Pathways APN Research Awards™ Program
3/10
04:25 pm
alks
Alkermes to Present at the Stifel 2026 Virtual CNS Forum [Yahoo! Finance]
Low
Report
Alkermes to Present at the Stifel 2026 Virtual CNS Forum [Yahoo! Finance]
3/10
04:00 pm
alks
Alkermes to Present at the Stifel 2026 Virtual CNS Forum
Low
Report
Alkermes to Present at the Stifel 2026 Virtual CNS Forum
2/27
12:03 am
alks
Alkermes plc Q4 2025 Earnings Call Summary [Yahoo! Finance]
Low
Report
Alkermes plc Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/26
10:59 am
alks
Alkermes (ALKS) had its price target raised by Wells Fargo & Company from $37.00 to $43.00. They now have an "overweight" rating on the stock.
Low
Report
Alkermes (ALKS) had its price target raised by Wells Fargo & Company from $37.00 to $43.00. They now have an "overweight" rating on the stock.
2/26
10:52 am
alks
Alkermes (ALKS) had its price target lowered by Royal Bank Of Canada from $47.00 to $45.00. They now have an "outperform" rating on the stock.
Low
Report
Alkermes (ALKS) had its price target lowered by Royal Bank Of Canada from $47.00 to $45.00. They now have an "outperform" rating on the stock.
2/26
07:17 am
alks
Alkermes (ALKS) had its "neutral" rating reaffirmed by HC Wainwright.
Low
Report
Alkermes (ALKS) had its "neutral" rating reaffirmed by HC Wainwright.
2/25
07:51 am
alks
Alkermes: Q4 Earnings Snapshot [Yahoo! Finance]
Medium
Report
Alkermes: Q4 Earnings Snapshot [Yahoo! Finance]
2/25
07:30 am
alks
Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2025 and Provides Financial Expectations for 2026 [Yahoo! Finance]
Medium
Report
Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2025 and Provides Financial Expectations for 2026 [Yahoo! Finance]
2/25
07:02 am
alks
Alkermes plc Announces CEO Succession Plan [Yahoo! Finance]
Medium
Report
Alkermes plc Announces CEO Succession Plan [Yahoo! Finance]
2/25
07:00 am
alks
Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2025 and Provides Financial Expectations for 2026
Medium
Report
Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2025 and Provides Financial Expectations for 2026
2/25
06:55 am
alks
Alkermes plc Announces CEO Succession Plan
Medium
Report
Alkermes plc Announces CEO Succession Plan
2/25
06:24 am
alks
Alkermes (ALKS) was upgraded by Wolfe Research to "strong-buy".
Medium
Report
Alkermes (ALKS) was upgraded by Wolfe Research to "strong-buy".
2/24
04:00 pm
alks
Alkermes to Present at the TD Cowen 46th Annual Health Care Conference
Medium
Report
Alkermes to Present at the TD Cowen 46th Annual Health Care Conference
2/23
06:01 pm
alks
Alkermes (NASDAQ:ALKS) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
Medium
Report
Alkermes (NASDAQ:ALKS) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
2/21
06:31 am
alks
Alkermes (NASDAQ:ALKS) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Low
Report
Alkermes (NASDAQ:ALKS) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
2/20
08:03 am
alks
Alkermes (NASDAQ:ALKS) had its price target raised by analysts at Bank of America Corporation from $33.00 to $34.00. They now have a "neutral" rating on the stock.
Low
Report
Alkermes (NASDAQ:ALKS) had its price target raised by analysts at Bank of America Corporation from $33.00 to $34.00. They now have a "neutral" rating on the stock.
2/12
07:30 am
alks
Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market
Medium
Report
Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market
2/11
04:00 pm
alks
Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026
Medium
Report
Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026
2/2
11:12 am
alks
Is Alkermes (ALKS) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]
Low
Report
Is Alkermes (ALKS) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]
1/15
07:46 am
alks
Alkermes (NASDAQ:ALKS) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Low
Report
Alkermes (NASDAQ:ALKS) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
1/7
04:12 am
alks
AstronauTx appoints experienced biotech executive Adam Rosenberg as Chair of the Board [Yahoo! Finance]
Low
Report
AstronauTx appoints experienced biotech executive Adam Rosenberg as Chair of the Board [Yahoo! Finance]
1/6
07:00 am
alks
Alixorexton Granted Breakthrough Therapy Designation by U.S. FDA for the Treatment of Narcolepsy Type 1
Low
Report
Alixorexton Granted Breakthrough Therapy Designation by U.S. FDA for the Treatment of Narcolepsy Type 1
1/5
09:02 pm
alks
????????????????:2032??90????????CAGR11.5%???????·???????? [CNET News]
Low
Report
????????????????:2032??90????????CAGR11.5%???????·???????? [CNET News]